@Article{Ścieżyńska2016,
journal="Klinika Oczna / Acta Ophthalmologica Polonica",
issn="0023-2157",
volume="118",
number="1",
year="2016",
title="Experimental studies on medical treatments of retinal dystrophies with a particular focus on ABCA4 retinopathies",
abstract="Retinal dystrophies are a group of hereditary diseases varying in clinical and etiological aspects. The most common central retinal dystrophy is Stargardt’s disease, which is mainly caused by mutations in the  ABCA4  gene. Dysfunction of the  ABCA4  gene product leads to accumulation of toxic metabolites of the visual cycle and consequently to the loss of photoreceptors and surrounding retinal pigment epithelial cells. This study summarizes various pharmacological attempts aimed at slowing the progression of retinal dystrophies, especially  ABCA4  retinopathies.",
author="Ścieżyńska, Aneta
and Oziębło, Dominika
and Ołdak, Monika",
pages="59--65",
doi="10.5114/ko.2016.71659",
url="http://dx.doi.org/10.5114/ko.2016.71659"
}